Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
Université de Montréal
$27,000.00
The Effects of Gender-Affirming Hormone Therapy on Ocular Parametrics among Transgender Population
EF 2025-26
Résumé
Transgender individuals are people whose gender identity do not align with their sex assigned at birth. For example, transgender men are biological female who self-identify as men, and transgender women are biological men who self-identify as women. One way to align the physical characteristics of the individual with their gender identity consists of taking sex hormones of the sex they identify. This treatment is called gender-affirming hormone therapy (GAHT), where transgender women take estrogen, testosterone blockers and/or progesterone, and transgender men take testosterone supplementation. Although a primary medical procedure, GAHT can lead to adverse effects in causing diverse metabolic and vascular changes, which may in turn increase the risk of developing various pathologies. The retina, at the back of the eye, is responsible of vision and is especially vulnerable to metabolic and vascular alterations. Thus, it is important to explore if GAHT poses a risk to the retina of transgenders undergoing hormonal supplementation chronically. My research project aims to (1) identify the functional and structural changes of the retina in transgenders undergoing GAHT. Since this population is still underrepresented in terms of health screening focus and at risk of developing various cardiovascular diseases and metabolic conditions, my project also aims to (2) provide the bases to revise optometric guidelines for transgender patients. Diverse ocular measures will be collected in trans- and cisgender individuals and will be linked with their sex hormone levels and gender. The findings will advance our understanding of the effects of hormones on the eyes, in addition to provide a comprehensive ocular image dataset for better ocular screening of transgender patients in Canada.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572603
Name
Li Xin Yi
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Effects of Gender-Affirming Hormone Therapy on Ocular Parametrics among Transgender Population
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Eye Function & Structure; Feminizing Hormone Therapy; Gender-Affirming Hormone Therapy; Health Equity; Masculinizing Hormone Therapy; Ocular Biometrics; Ocular Health; Optometric Guidelines; Sex Steroid Hormones; Transgender Population
Abstract
Transgender individuals are people whose gender identity do not align with their sex assigned at birth. For example, transgender men are biological female who self-identify as men, and transgender women are biological men who self-identify as women. One way to align the physical characteristics of the individual with their gender identity consists of taking sex hormones of the sex they identify. This treatment is called gender-affirming hormone therapy (GAHT), where transgender women take estrogen, testosterone blockers and/or progesterone, and transgender men take testosterone supplementation. Although a primary medical procedure, GAHT can lead to adverse effects in causing diverse metabolic and vascular changes, which may in turn increase the risk of developing various pathologies. The retina, at the back of the eye, is responsible of vision and is especially vulnerable to metabolic and vascular alterations. Thus, it is important to explore if GAHT poses a risk to the retina of transgenders undergoing hormonal supplementation chronically. My research project aims to (1) identify the functional and structural changes of the retina in transgenders undergoing GAHT. Since this population is still underrepresented in terms of health screening focus and at risk of developing various cardiovascular diseases and metabolic conditions, my project also aims to (2) provide the bases to revise optometric guidelines for transgender patients. Diverse ocular measures will be collected in trans- and cisgender individuals and will be linked with their sex hormone levels and gender. The findings will advance our understanding of the effects of hormones on the eyes, in addition to provide a comprehensive ocular image dataset for better ocular screening of transgender patients in Canada.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Xin Yi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~